Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Merrimack Pharma

Roche - Basel

EU backs Roche’s Kadcyla in breast cancer

Green light for Herceptin follow-up

Bayer symbol

EU approval for Bayer’s prostate cancer drug

Xofigo wins marketing authorisation from European Commission

Deal Watch table for October 2013

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

Pharma deals during October 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Novartis building

Novartis offloads diagnostics unit to Grifols for $1.7bn

Part of strategy to focus on more profitable businesses

- PMLiVE

Salix boosts GI portfolio with $2.6bn deal for Santarus

Will reduce company’s reliance on diarrhoea treatment Xifaxan

- PMLiVE

Endo agrees $1.6bn deal to buy Paladin Labs

Gives company access to Canada and emerging markets

- PMLiVE

Publicis adds Heartbeat to portfolio

Digital agency will merge with Saatchi Health agencies in the US

Roche - Basel

Roche signs €400m superbug deal

Buys rights to investigational antibiotic from Polyphor

- PMLiVE

Late-stage ovarian cancer

Novel treatment strategies have yielded several promising agents that have reached phase III

- PMLiVE

Priority review for Lilly’s ramucirumab in gastric cancer

Update comes as company posts improved revenue results

- PMLiVE

Public unaware of main cause of liver cancer

Janssen-backed survey finds one in six people is aware of viral hepatitis role in the disease

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links